FDA approves Biotronik's "smaller, thinner" heart rhythm implants

May 7, 2013 by Arezu Sarvestani

Biotronik wins FDA approval for its next-generation Ilesto 7 suite of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators.

Biotronik logo

German medical device maker Biotronik today touted FDA approval for its Ilesto 7 line of next-generation implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators.

The devices are smaller, thinner and lighter and the new Ilesto DX allows physicians to monitor atrial information and possibly diagnose previously undetected instance of atrial fibrillation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp